![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
X
20
Lianyungang Guike Pharmaceutical Co., Ltd. Lianyungang Cn, based in China, is a pharmaceutical company.
One of their significant offerings is Atracurium besilate, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2013-019 - Rev 00
This Chemical Type CEP, issued on February 26, 2020, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1970 associated with this CEP further emphasizes